Skip to main content
OpenTrials

Clinical trial condition

Mononegavirales Infections

Explore clinical trials studying Mononegavirales Infections. Study availability and eligibility vary by location and protocol.

536 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Mononegavirales Infections trial results

Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

NCT05559476

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Tempe, Arizona, United States
  • GSK Investigational Site Canoga Park, California, United States
  • GSK Investigational Site Colton, California, United States
View all 46 locations
View Trial Details
Completed

Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

NCT05964582

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Quality Clinical Research - 10040 Regency Cir - HyperCore - PPDS Site Number : 8400001 Omaha, Nebraska, United States
  • Senders Pediatrics Site Number : 8400002 Cleveland, Ohio, United States
  • Investigational Site Number : 2460002 Helsinki, Finland
  • Investigational Site Number : 2460001 Jarvenpaa, Finland
View all 15 locations
View Trial Details
Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

NCT04841577

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Auckland, New Zealand
  • GSK Investigational Site Auckland, New Zealand
  • GSK Investigational Site Christchurch, New Zealand
  • GSK Investigational Site Havelock North, New Zealand
View all 14 locations
View Trial Details
Completed

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

NCT04138056

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Rochester, New York, United States
  • GSK Investigational Site Seattle, Washington, United States
View Trial Details
Completed

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

NCT02545517

Conditions
Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Vienna, Austria
  • GSK Investigational Site Munich, Bavaria, Germany
  • GSK Investigational Site Rostock, Mecklenburg-Vorpommern, Germany
  • GSK Investigational Site Berlin, Germany
View Trial Details
Completed

Disease Burden of RSV

NCT05506670

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • Centre d'Investigation Clinique de Lyon- Groupement Hospitalier Est- Hospices Civils de Lyon Bron, Rhone, France
  • Maison Médicale de l'Enfant Écully, Rhone, France
  • Cabinet CAPELLI Lyon, Rhone, France
  • Maison Médicale de l'Enfant Écully, Rhône, France
View Trial Details

Related conditions